Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology
We read the commentary by Fusco et al [...]
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-05-01
|
| Series: | Dentistry Journal |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2304-6767/7/2/54 |
| _version_ | 1811184569437650944 |
|---|---|
| author | Noopur Raje Evangelos Terpos Danielle D. Jandial |
| author_facet | Noopur Raje Evangelos Terpos Danielle D. Jandial |
| author_sort | Noopur Raje |
| collection | DOAJ |
| description | We read the commentary by Fusco et al [...] |
| first_indexed | 2024-04-11T13:14:28Z |
| format | Article |
| id | doaj.art-29238e3ea1644a0d93abfd8cdd2b6727 |
| institution | Directory Open Access Journal |
| issn | 2304-6767 |
| language | English |
| last_indexed | 2024-04-11T13:14:28Z |
| publishDate | 2019-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Dentistry Journal |
| spelling | doaj.art-29238e3ea1644a0d93abfd8cdd2b67272022-12-22T04:22:26ZengMDPI AGDentistry Journal2304-67672019-05-01725410.3390/dj7020054dj7020054Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet OncologyNoopur Raje0Evangelos Terpos1Danielle D. Jandial2Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USASchool of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, 11528 Athens, GreeceAmgen Inc., Thousand Oaks, CA 91320, USAWe read the commentary by Fusco et al [...]https://www.mdpi.com/2304-6767/7/2/54n/a |
| spellingShingle | Noopur Raje Evangelos Terpos Danielle D. Jandial Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology Dentistry Journal n/a |
| title | Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology |
| title_full | Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology |
| title_fullStr | Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology |
| title_full_unstemmed | Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology |
| title_short | Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology |
| title_sort | response to comment osteonecrosis of the jaw in myeloma patients receiving denosumab or zoledronic acid comment on pivotal trial by raje et al published in lancet oncology |
| topic | n/a |
| url | https://www.mdpi.com/2304-6767/7/2/54 |
| work_keys_str_mv | AT noopurraje responsetocommentosteonecrosisofthejawinmyelomapatientsreceivingdenosumaborzoledronicacidcommentonpivotaltrialbyrajeetalpublishedinlancetoncology AT evangelosterpos responsetocommentosteonecrosisofthejawinmyelomapatientsreceivingdenosumaborzoledronicacidcommentonpivotaltrialbyrajeetalpublishedinlancetoncology AT danielledjandial responsetocommentosteonecrosisofthejawinmyelomapatientsreceivingdenosumaborzoledronicacidcommentonpivotaltrialbyrajeetalpublishedinlancetoncology |